Merck (MRK) Payout Ratio (2009 - 2026)

Merck (MRK) has reported Payout Ratio for 18 consecutive years, with 1.6 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payout Ratio fell 441.87% year-over-year to 1.6 in Q2 2026; TTM through Jun 2026 was 2.62, a 435.31% increase from a year earlier, with the FY2025 full-year figure at 0.45, down 2.17% from the prior year.
• Payout Ratio was 1.6 for Q2 2026 at Merck, down from 0.5 in the prior quarter.
• Over five years, Payout Ratio peaked at 0.68 in Q4 2025 and troughed at 1.6 in Q2 2026.
• A 5-year average of 0.16 and a median of 0.41 in 2022 frame the typical range for Payout Ratio.
• Across the five-year window, Payout Ratio surged 215.22% in 2024 and slumped 441.87% in 2026, its largest moves.
• Over 5 years, Payout Ratio stood at 0.58 in 2022, then sank by 360.51% to 1.51 in 2023, then surged by 134.5% to 0.52 in 2024, then soared by 30.74% to 0.68 in 2025, then slumped by 335.37% to 1.6 in 2026.
• The last three Payout Ratio figures came in at 1.6 (Q2 2026), 0.5 (Q1 2026), and 0.68 (Q4 2025), per Business Quant data.